Lam Research (NASDAQ:LRCX) Trading Down 3.4% – Here’s Why

Lam Research Corporation (NASDAQ:LRCX) dropped 3.4% on Thursday . The stock traded as low as $219.76 and last traded at $220.70. Approximately 11,469,361 shares traded hands during trading, a decline of 20% from the average daily volume of 14,260,832 shares. The stock had previously closed at $228.39.

Lam Research News Roundup

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Zacks upgraded LRCX from “hold” to “strong-buy,” signaling renewed analyst conviction that the company can keep outperforming as semiconductor demand remains strong. Read More.
• Positive Sentiment: Zacks highlights Lam’s track record of beating estimates and says the company currently has the key drivers (momentum + favorable fundamentals) that make another earnings beat likely. Upcoming results are a potential catalyst. Read More.
• Positive Sentiment: Lam was added to Zacks Rank #1 (Strong Buy) momentum lists and recently outperformed the broader market, underscoring short-term bullish analyst sentiment and investor interest. Read More.
• Positive Sentiment: Seeking Alpha and other coverage argue Lam benefits as chipmakers shift to “vertical” and more advanced process steps — a structural tailwind for Lam’s wafer-fabrication tools and recurring high-margin revenue. Read More.
• Positive Sentiment: Some analyst compilations (Benzinga) show upside scenarios — several firms project double-digit upside for LRCX, which keeps bullish price-target chatter alive. Read More.
• Neutral Sentiment: Jim Cramer called Lam “the best of the best” but cautioned against buying into parabolic moves — positive endorsement balanced by a warning about buying at extreme momentum. Read More.
• Neutral Sentiment: MarketBeat compared Lam favorably to peers for recurring, high-margin revenue and strong recent sales, but framed this inside a broader industry comparison — useful context but not an immediate catalyst. Read More.
• Negative Sentiment: MarketBeat and some analyst notes caution that Lam’s rapid 2025 rally may be overextended; certain analyst aggregates now forecast a near-term cooling with downside from current levels, which could pressure the stock if earnings or guidance disappoint. Read More.
• Neutral Sentiment: Investors should watch the imminent earnings release — Zacks and others flag it as the primary near-term catalyst that could validate the bullish case or trigger a pullback. Read More.

Analyst Ratings Changes

A number of brokerages have commented on LRCX. JPMorgan Chase & Co. upped their price objective on shares of Lam Research from $113.00 to $165.00 and gave the stock an “overweight” rating in a research report on Thursday, October 23rd. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $260.00 price target (up from $195.00) on shares of Lam Research in a report on Wednesday. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $225.00 price objective (up previously from $175.00) on shares of Lam Research in a report on Monday, January 12th. BNP Paribas Exane boosted their target price on Lam Research from $80.00 to $140.00 and gave the stock a “neutral” rating in a research report on Thursday, October 23rd. Finally, Wells Fargo & Company set a $250.00 price target on Lam Research and gave the company an “overweight” rating in a report on Thursday, January 15th. One investment analyst has rated the stock with a Strong Buy rating, twenty-seven have assigned a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $198.75.

Lam Research Stock Down 3.4%

The stock has a market cap of $277.21 billion, a price-to-earnings ratio of 48.61, a P/E/G ratio of 2.55 and a beta of 1.77. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. The firm’s 50 day moving average is $175.34 and its two-hundred day moving average is $139.90.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The business’s revenue for the quarter was up 27.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.86 EPS. On average, sell-side analysts predict that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd were paid a dividend of $0.26 per share. The ex-dividend date of this dividend was Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.5%. Lam Research’s dividend payout ratio is currently 22.91%.

Insider Buying and Selling

In related news, insider Ava Harter sold 9,010 shares of the firm’s stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $157.47, for a total value of $1,418,804.70. Following the sale, the insider directly owned 56,786 shares of the company’s stock, valued at approximately $8,942,091.42. This trade represents a 13.69% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total transaction of $207,667.02. Following the transaction, the director directly owned 1,652 shares of the company’s stock, valued at $264,303.48. This trade represents a 44.00% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 50,418 shares of company stock valued at $7,667,305. Insiders own 0.31% of the company’s stock.

Institutional Investors Weigh In On Lam Research

Institutional investors have recently added to or reduced their stakes in the company. PMV Capital Advisers LLC purchased a new stake in shares of Lam Research during the 4th quarter worth about $25,000. IMG Wealth Management Inc. purchased a new stake in Lam Research during the second quarter worth approximately $26,000. Stance Capital LLC acquired a new stake in shares of Lam Research in the third quarter worth $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research in the second quarter worth $27,000. Finally, Triumph Capital Management purchased a new position in shares of Lam Research in the 3rd quarter valued at $27,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.